Back to Search Start Over

Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML

Authors :
Löwenberg, B. (Bob)
Pabst, T. (Thomas)
Maertens, J. (Johan)
Norden, Y. (Yvette) van
Biemond, B.J. (Bart J.)
Schouten, H. (Harry)
Spertini, O. (Olivier)
Vellenga, E. (Edo)
Graux, C. (Carlos)
Havelange, V. (Violaine)
Greef, G.E. (Georgine) de
Weerdt, O. (Okke) de
Legdeur, M.C.J.C. (M. C J C)
Kuball, J. (Jürgen)
Marwijk Kooy, M. (Marinus) van
Gjertsen, B.T. (Bjorn T.)
Jongen-Lavrencic, M. (Mojca)
Loosdrecht, A.A. (Arjan) van de
van Lammeren - Venema, D. (Danielle)
Hodossy, B. (Beata)
Breems, D.A. (Dimitri)
Chalandon, Y. (Yves)
Passweg, J. (Jakob Robert)
Valk, P.J.M. (Peter)
Manz, M.G.
Ossenkoppele, G.J. (Gert)
Löwenberg, B. (Bob)
Pabst, T. (Thomas)
Maertens, J. (Johan)
Norden, Y. (Yvette) van
Biemond, B.J. (Bart J.)
Schouten, H. (Harry)
Spertini, O. (Olivier)
Vellenga, E. (Edo)
Graux, C. (Carlos)
Havelange, V. (Violaine)
Greef, G.E. (Georgine) de
Weerdt, O. (Okke) de
Legdeur, M.C.J.C. (M. C J C)
Kuball, J. (Jürgen)
Marwijk Kooy, M. (Marinus) van
Gjertsen, B.T. (Bjorn T.)
Jongen-Lavrencic, M. (Mojca)
Loosdrecht, A.A. (Arjan) van de
van Lammeren - Venema, D. (Danielle)
Hodossy, B. (Beata)
Breems, D.A. (Dimitri)
Chalandon, Y. (Yves)
Passweg, J. (Jakob Robert)
Valk, P.J.M. (Peter)
Manz, M.G.
Ossenkoppele, G.J. (Gert)
Publication Year :
2017

Abstract

Clofarabine has demonstrated antileukemic activity in acute myeloid leukemia (AML) but has yet to be critically evaluated in younger adults in the frontline with standard chemotherapy. We compared 2 induction regimens in newly diagnosed patients ages 18 to 65 with acute myeloid leuk

Details

Database :
OAIster
Notes :
Blood vol. 129 no. 12, pp. 1636-1645, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1042809114
Document Type :
Electronic Resource
Full Text :
https://doi.org/10.1182.blood-2016-10-740613
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details